β-Escin Overcomes Trastuzumab Resistance in HER2-Positive Breast Cancer by Targeting Cancer Stem-Like Features

The effect of β-escin on trastuzumab-resistant and -sensitive cell lines in vitro was evaluated for apoptosis, expression of HER2 family members, and impact on CSC-like properties.